Evidence map›Paper›PMID 39703726›Full record

ArticleTransplantation direct2025

Deceased Donor Renal Allograft Utility in Adult Single and Multi-organ Transplantation in the United States.

Peter J Altshuler, Adam S Bodzin, Kenneth A Andreoni, Pooja Singh, Anju Yadav, Jaime M Glorioso, Ashesh P Shah, Carlo Gerado B Ramirez, Warren R Maley, Adam M Frank

Abstract read
In one paragraph

Article in Transplantation direct, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Peter J AltshulerDepartment of Surgery, Division of Transplant Surgery, University of California San Francisco, San Francisco, CA.
Adam S BodzinDepartment of Surgery, Division of Transplantation, Thomas Jefferson University Hospital, Philadelphia, PA.
Kenneth A AndreoniDepartment of Surgery, Division of Transplantation, Thomas Jefferson University Hospital, Philadelphia, PA.
Pooja SinghDepartment of Medicine, Division of Nephrology, Thomas Jefferson University Hospital, Philadelphia, PA.
Anju YadavDepartment of Medicine, Division of Nephrology, Thomas Jefferson University Hospital, Philadelphia, PA.
Jaime M GloriosoDepartment of Surgery, Division of Transplantation, Thomas Jefferson University Hospital, Philadelphia, PA.
Ashesh P ShahDepartment of Surgery, Division of Transplantation, Thomas Jefferson University Hospital, Philadelphia, PA.
Carlo Gerado B RamirezDepartment of Surgery, Division of Transplantation, Thomas Jefferson University Hospital, Philadelphia, PA.
Warren R MaleyDepartment of Surgery, Division of Transplantation, Thomas Jefferson University Hospital, Philadelphia, PA.
Adam M FrankDepartment of Surgery, Division of Transplantation, Thomas Jefferson University Hospital, Philadelphia, PA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Deceased donor multiorgan transplants utilizing kidneys (MOTs) can improve outcomes for multiorgan recipients but reduces kidneys for chronic renal failure patients. Methods: We reviewed the Organ Procurement and Transplantation Network database from 2015 through 2019, for adult deceased donor kidney transplants. Recipients were classified as kidney transplant alone (KTA) (n = 62,252) or MOTs pancreas-kidney, simultaneous pancreas-kidney (n = 3,976), liver-kidney, simultaneous liver-kidney (n = 3,212), heart-kidney, simultaneous heart-kidney (n = 808), and "other"-kidney, simultaneous "other" kidney (n = 73). Results: Liver, heart, and lung-alone transplants were at least 7 times more frequent than their MOT correlate, whereas the inverse was true with pancreas transplantation with SPKs being by far the most common pancreas transplant type. On average, KTA recipients waited between 2.8 and 21.4 times longer than MOTs, with SPKs waiting the longest of the MOT types. Predialysis initiation transplants were less frequent in KTAs compared with MOTs. Use of high-quality grafts according to Kidney Donor Profile Index < 35% was frequent among MOTs, but uncommon in KTAs who had an Estimated Post Transplant Survival score (EPTS) of >20%. For recipients older than 65, SPKs and SOKs were rare, but SLKs and SHKs had a higher fraction of recipients than KTAs and were much more likely to use a Kidney Donor Profile Index <35% kidney. SPKs and KTAs with an EPTS ≤20% had the best kidney graft survival. KTAs with an EPTS ≤80% had better kidney graft survival than SLKs, SHKs, and SOKs. Conclusions: This study highlights disparities in access to deceased donor kidneys for kidney-alone candidates versus MOTs and suggests opportunities to improve allocation.

Identifiers

PMID39703726
PMCPMC11658743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.